Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

906301

registered interest
date	17/05/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Learning Disability: Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department plans to allocation additional funding to the Learning Disability Mortality Review Programme to ensure the completion of the outstanding reviews into avoidable deaths of people with learning disabilities.
tabling member constituency	Worsley and Eccles South
tabling member printed	Barbara Keeley
uin	145295
answer	answer is ministerial correction date of answer 22/05/2018 answer text <p>NHS England has allocated an additional £1.4 million for clinical commissioning group/sustainability and transformation partnership areas to support the delivery of the Learning Disability Mortality Review Programme in 2018/19 in its agreed fourth year of operation. This will facilitate the better establishment and running of the local mortality review programmes and reduce the backlog of mortality reviews. The learning from the reviews is being used to inform work on programmes such as increasing general practitioner annual health checks, care pathways for key mortality issues such as sepsis, epilepsy and constipation, for example, alongside other learning disability health practice improvement work.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 22/05/2018 12:34:08 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1588 label Biography information for Baroness Keeley

906302

registered interest
date	17/05/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Learning Disability: Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what criteria NHS England will use to monitor the quality of the remaining reviews into the early deaths of people with learning disabilities notified to the Learning Disability Mortality Review Programme.
tabling member constituency	Worsley and Eccles South
tabling member printed	Barbara Keeley
uin	145296
answer	answer is ministerial correction date of answer 22/05/2018 answer text <p>The Department has been informed by NHS England that NHS England follows the University of Bristol Learning Disability Mortality Review Programme guidance methodology on quality assuring reviews. The University of Bristol provides a quality assurance role as part of the programme alongside local steering groups.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 22/05/2018 12:32:59 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1588 label Biography information for Baroness Keeley

906303

registered interest
date	17/05/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Learning Disability: Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether NHS England plans to publish regular progress reports on the remaining reviews into the early deaths of people with learning disabilities notified to the Learning Disability Mortality Review Programme.
tabling member constituency	Worsley and Eccles South
tabling member printed	Barbara Keeley
uin	145297
answer	answer is ministerial correction date of answer 22/05/2018 answer text <p>NHS England has informed us that it plans to publish further reports by the University of Bristol relating to the Learning Disability Mortality Review Programme, through its contract arrangement with the Healthcare Quality Improvement Partnership.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 22/05/2018 12:32:07 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1588 label Biography information for Baroness Keeley

906348

registered interest
date	17/05/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much funding from the public purse was allocated to biomedical research into Myalgic Encephalomyelitis 2014-2015.
tabling member constituency	Glasgow North West
tabling member printed	Carol Monaghan
uin	145354
answer	answer is ministerial correction date of answer 22/05/2018 answer text <p>In the period in question, the major National Institute for Health Research (NIHR) funding for biomedical research was through its Biomedical Research Centres and Units. These support research funded by the NIHR itself and also research funded by other public, charity and industry research funders. The level of funding for biomedical research into chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) for each financial year can be found in the table below. The funding for this research came from a combination of funders.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2014-15</p></td><td><p>280,442</p></td></tr><tr><td><p>2015-16</p></td><td><p>295,626</p></td></tr><tr><td><p>2016-17</p></td><td><p>130,958</p></td></tr></tbody></table><p> </p><p>The NIHR Clinical Research Network (CRN) provides the infrastructure that allows high-quality clinical research funded by charities, research funders and life-sciences industry to be undertaken throughout the National Health Service. The level of funding for biomedical research into CFS/ME for each financial year can be found in the table below. The funding for this research came from a combination of the NIHR, the Medical Research Council (MRC) and medical research charities. Expenditure from the CRN coordinating centre itself is also outlined below:</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>CRN funding for research, £</p></td><td><p>Coordinating expenditure, £</p></td></tr><tr><td><p>2014-15</p></td><td><p>134,769</p></td><td><p>17,485</p></td></tr><tr><td><p>2015-16</p></td><td><p>125,176</p></td><td><p>17,796</p></td></tr><tr><td><p>2016-17</p></td><td><p>82,866</p></td><td><p>7,821</p></td></tr></tbody></table><p> </p><p>The MRC spend on research directly relating to CFS/ME can be found in the following table. Research into CFS/ME is a continuing priority for the MRC.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2014-15</p></td><td><p>652,044</p></td></tr><tr><td><p>2015-16</p></td><td><p>287,234</p></td></tr><tr><td><p>2016-17</p></td><td><p>286,197</p></td></tr></tbody></table><p> </p><p>The NIHR and the MRC welcomes funding applications for research into any aspect of human health, including biomedical research into CFS/ME. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. On this basis, it is not possible to say how much funding is planned in the current financial year.</p><p> </p><p>The NIHR recognises that CFS/ME is a debilitating condition and is speaking with the United Kingdom CFS/ME Research Collaborative and patient representatives about how best we can support a joined up approach to high quality research into this complex disorder.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 145355 145356 145357 question first answered 22/05/2018 12:30:42 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4443 label Biography information for Carol Monaghan

906350

registered interest
date	17/05/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much funding from the public purse was allocated to biomedical research into Myalgic Encephalomyelitis 2015-2016.
tabling member constituency	Glasgow North West
tabling member printed	Carol Monaghan
uin	145355
answer	answer is ministerial correction date of answer 22/05/2018 answer text <p>In the period in question, the major National Institute for Health Research (NIHR) funding for biomedical research was through its Biomedical Research Centres and Units. These support research funded by the NIHR itself and also research funded by other public, charity and industry research funders. The level of funding for biomedical research into chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) for each financial year can be found in the table below. The funding for this research came from a combination of funders.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2014-15</p></td><td><p>280,442</p></td></tr><tr><td><p>2015-16</p></td><td><p>295,626</p></td></tr><tr><td><p>2016-17</p></td><td><p>130,958</p></td></tr></tbody></table><p> </p><p>The NIHR Clinical Research Network (CRN) provides the infrastructure that allows high-quality clinical research funded by charities, research funders and life-sciences industry to be undertaken throughout the National Health Service. The level of funding for biomedical research into CFS/ME for each financial year can be found in the table below. The funding for this research came from a combination of the NIHR, the Medical Research Council (MRC) and medical research charities. Expenditure from the CRN coordinating centre itself is also outlined below:</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>CRN funding for research, £</p></td><td><p>Coordinating expenditure, £</p></td></tr><tr><td><p>2014-15</p></td><td><p>134,769</p></td><td><p>17,485</p></td></tr><tr><td><p>2015-16</p></td><td><p>125,176</p></td><td><p>17,796</p></td></tr><tr><td><p>2016-17</p></td><td><p>82,866</p></td><td><p>7,821</p></td></tr></tbody></table><p> </p><p>The MRC spend on research directly relating to CFS/ME can be found in the following table. Research into CFS/ME is a continuing priority for the MRC.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2014-15</p></td><td><p>652,044</p></td></tr><tr><td><p>2015-16</p></td><td><p>287,234</p></td></tr><tr><td><p>2016-17</p></td><td><p>286,197</p></td></tr></tbody></table><p> </p><p>The NIHR and the MRC welcomes funding applications for research into any aspect of human health, including biomedical research into CFS/ME. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. On this basis, it is not possible to say how much funding is planned in the current financial year.</p><p> </p><p>The NIHR recognises that CFS/ME is a debilitating condition and is speaking with the United Kingdom CFS/ME Research Collaborative and patient representatives about how best we can support a joined up approach to high quality research into this complex disorder.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 145354 145356 145357 question first answered 22/05/2018 12:30:42 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4443 label Biography information for Carol Monaghan

906352

registered interest
date	17/05/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much funding from the public purse was allocated to biomedical research into Myalgic Encephalomyelitis 2016-2017.
tabling member constituency	Glasgow North West
tabling member printed	Carol Monaghan
uin	145356
answer	answer is ministerial correction date of answer 22/05/2018 answer text <p>In the period in question, the major National Institute for Health Research (NIHR) funding for biomedical research was through its Biomedical Research Centres and Units. These support research funded by the NIHR itself and also research funded by other public, charity and industry research funders. The level of funding for biomedical research into chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) for each financial year can be found in the table below. The funding for this research came from a combination of funders.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2014-15</p></td><td><p>280,442</p></td></tr><tr><td><p>2015-16</p></td><td><p>295,626</p></td></tr><tr><td><p>2016-17</p></td><td><p>130,958</p></td></tr></tbody></table><p> </p><p>The NIHR Clinical Research Network (CRN) provides the infrastructure that allows high-quality clinical research funded by charities, research funders and life-sciences industry to be undertaken throughout the National Health Service. The level of funding for biomedical research into CFS/ME for each financial year can be found in the table below. The funding for this research came from a combination of the NIHR, the Medical Research Council (MRC) and medical research charities. Expenditure from the CRN coordinating centre itself is also outlined below:</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>CRN funding for research, £</p></td><td><p>Coordinating expenditure, £</p></td></tr><tr><td><p>2014-15</p></td><td><p>134,769</p></td><td><p>17,485</p></td></tr><tr><td><p>2015-16</p></td><td><p>125,176</p></td><td><p>17,796</p></td></tr><tr><td><p>2016-17</p></td><td><p>82,866</p></td><td><p>7,821</p></td></tr></tbody></table><p> </p><p>The MRC spend on research directly relating to CFS/ME can be found in the following table. Research into CFS/ME is a continuing priority for the MRC.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2014-15</p></td><td><p>652,044</p></td></tr><tr><td><p>2015-16</p></td><td><p>287,234</p></td></tr><tr><td><p>2016-17</p></td><td><p>286,197</p></td></tr></tbody></table><p> </p><p>The NIHR and the MRC welcomes funding applications for research into any aspect of human health, including biomedical research into CFS/ME. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. On this basis, it is not possible to say how much funding is planned in the current financial year.</p><p> </p><p>The NIHR recognises that CFS/ME is a debilitating condition and is speaking with the United Kingdom CFS/ME Research Collaborative and patient representatives about how best we can support a joined up approach to high quality research into this complex disorder.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 145354 145355 145357 question first answered 22/05/2018 12:30:42 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4443 label Biography information for Carol Monaghan

906353

registered interest
date	17/05/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much funding from the public purse he plans to allocate to biomedical research into Myalgic Encephalomyelitis in the current financial year.
tabling member constituency	Glasgow North West
tabling member printed	Carol Monaghan
uin	145357
answer	answer is ministerial correction date of answer 22/05/2018 answer text <p>In the period in question, the major National Institute for Health Research (NIHR) funding for biomedical research was through its Biomedical Research Centres and Units. These support research funded by the NIHR itself and also research funded by other public, charity and industry research funders. The level of funding for biomedical research into chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) for each financial year can be found in the table below. The funding for this research came from a combination of funders.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2014-15</p></td><td><p>280,442</p></td></tr><tr><td><p>2015-16</p></td><td><p>295,626</p></td></tr><tr><td><p>2016-17</p></td><td><p>130,958</p></td></tr></tbody></table><p> </p><p>The NIHR Clinical Research Network (CRN) provides the infrastructure that allows high-quality clinical research funded by charities, research funders and life-sciences industry to be undertaken throughout the National Health Service. The level of funding for biomedical research into CFS/ME for each financial year can be found in the table below. The funding for this research came from a combination of the NIHR, the Medical Research Council (MRC) and medical research charities. Expenditure from the CRN coordinating centre itself is also outlined below:</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>CRN funding for research, £</p></td><td><p>Coordinating expenditure, £</p></td></tr><tr><td><p>2014-15</p></td><td><p>134,769</p></td><td><p>17,485</p></td></tr><tr><td><p>2015-16</p></td><td><p>125,176</p></td><td><p>17,796</p></td></tr><tr><td><p>2016-17</p></td><td><p>82,866</p></td><td><p>7,821</p></td></tr></tbody></table><p> </p><p>The MRC spend on research directly relating to CFS/ME can be found in the following table. Research into CFS/ME is a continuing priority for the MRC.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2014-15</p></td><td><p>652,044</p></td></tr><tr><td><p>2015-16</p></td><td><p>287,234</p></td></tr><tr><td><p>2016-17</p></td><td><p>286,197</p></td></tr></tbody></table><p> </p><p>The NIHR and the MRC welcomes funding applications for research into any aspect of human health, including biomedical research into CFS/ME. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. On this basis, it is not possible to say how much funding is planned in the current financial year.</p><p> </p><p>The NIHR recognises that CFS/ME is a debilitating condition and is speaking with the United Kingdom CFS/ME Research Collaborative and patient representatives about how best we can support a joined up approach to high quality research into this complex disorder.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 145354 145355 145356 question first answered 22/05/2018 12:30:42 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4443 label Biography information for Carol Monaghan

906433

registered interest
date	17/05/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Social Services: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 February 2018 to Question 128062 on social services: minimum wage, if he will provide funding to reimburse the historical capital costs of social care sector organisations.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	145320
answer	answer is ministerial correction date of answer 22/05/2018 answer text <p>The Government recognises the pressures that sleep-in liabilities are placing on social care providers and is exploring options to minimise any impact on the sector. Any intervention to support the sector would need to be proportionate and necessary.</p><p> </p><p>In the interim the Government will continue to work closely with stakeholders to ensure that we have a clear understanding of any impact the sector may face.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 22/05/2018 11:01:54 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4036 label Biography information for Luciana Berger

905555

registered interest
date	16/05/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Babies: Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when the Health Service Investigation Branch plans to being its investigation into avoidable baby deaths.
tabling member constituency	Weaver Vale
tabling member printed	Mike Amesbury
uin	144994
answer	answer is ministerial correction date of answer 21/05/2018 answer text <p>In November 2017, my Rt. hon. Friend the Secretary of State announced that, from April 2018, the Health Service Investigation Branch (HSIB) would investigate each case of early neonatal death, term intrapartum stillbirth and severe brain injury in babies, as well as each case of maternal death in England. This remit and the definition of qualifying maternity cases was set out in the Secretary of State’s directions, NHS Trust Development Authority (HSIB Maternity Investigations) Directions 2018, published on 26 April 2018.</p><p> </p><p>The new investigative approach began in a single region in April 2018 and will roll out to all areas of England during 2018/19. Rollout will be complete by the end of March 2019. It is estimated that there are approximately 1,000 cases of birth-related deaths or serious brain injuries in babies in England every year. The expectation is that the learning from investigations will spur system improvements leading to fewer deaths and injuries in the future.</p><p> </p><p>The HSIB has been allocated £8 million of additional funding to implement the new maternity investigation programme in 2018/19.</p><p> </p><p>The HSIB will produce an investigation report for each maternity investigation it undertakes and will make recommendations to the relevant National Health Service trust or foundation trust.</p><p> </p><p>It will be for individual trusts to put into place actions to address the recommendations of individual reports and ensure that the learning from HSIB investigations is put into practice so that avoidable harms are reduced. The Care Quality Commission, which monitors, inspects and regulates NHS providers does, in carrying out its functions, take into account a variety of data and intelligence sources. The HSIB maternity investigation recommendations and the actions NHS trusts and foundation trusts have taken in response could form part of these data sources and be taken into account where relevant.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 144995 144996 question first answered 21/05/2018 14:01:43 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4667 label Biography information for Mike Amesbury

905556

registered interest
date	16/05/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Babies: Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what additional (a) funding and (b) resources have been allocated to the Health Service Investigation Branch for its investigation into avoidable baby deaths; and what the timeframe is for that funding.
tabling member constituency	Weaver Vale
tabling member printed	Mike Amesbury
uin	144995
answer	answer is ministerial correction date of answer 21/05/2018 answer text <p>In November 2017, my Rt. hon. Friend the Secretary of State announced that, from April 2018, the Health Service Investigation Branch (HSIB) would investigate each case of early neonatal death, term intrapartum stillbirth and severe brain injury in babies, as well as each case of maternal death in England. This remit and the definition of qualifying maternity cases was set out in the Secretary of State’s directions, NHS Trust Development Authority (HSIB Maternity Investigations) Directions 2018, published on 26 April 2018.</p><p> </p><p>The new investigative approach began in a single region in April 2018 and will roll out to all areas of England during 2018/19. Rollout will be complete by the end of March 2019. It is estimated that there are approximately 1,000 cases of birth-related deaths or serious brain injuries in babies in England every year. The expectation is that the learning from investigations will spur system improvements leading to fewer deaths and injuries in the future.</p><p> </p><p>The HSIB has been allocated £8 million of additional funding to implement the new maternity investigation programme in 2018/19.</p><p> </p><p>The HSIB will produce an investigation report for each maternity investigation it undertakes and will make recommendations to the relevant National Health Service trust or foundation trust.</p><p> </p><p>It will be for individual trusts to put into place actions to address the recommendations of individual reports and ensure that the learning from HSIB investigations is put into practice so that avoidable harms are reduced. The Care Quality Commission, which monitors, inspects and regulates NHS providers does, in carrying out its functions, take into account a variety of data and intelligence sources. The HSIB maternity investigation recommendations and the actions NHS trusts and foundation trusts have taken in response could form part of these data sources and be taken into account where relevant.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 144994 144996 question first answered 21/05/2018 14:01:43 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4667 label Biography information for Mike Amesbury